Comment on CMS-2026-2081-0001

Summary: Susan G. Komen, a nonprofit breast cancer organization, supports the RFI while urging CMS to ensure the Essential Health Benefits (EHB) framework protects patients from burdensome utilization management and covers critical services. They specifically advocate for prohibiting step therapy for metastatic cancer, closing loopholes for prescription drug coverage, ensuring oral parity for anti-cancer drugs, and including patient navigation, genetic counseling, and biomarker testing as EHBs.